Provided by Tiger Trade Technology Pte. Ltd.

Revolution Medicines, Inc.

188.12
-12.7500-6.35%
Post-market: 190.902.78+1.48%18:42 EDT
Volume:4.86M
Turnover:903.26M
Market Cap:40.32B
PE:-21.09
High:199.64
Open:198.51
Low:180.49
Close:200.87
52wk High:224.31
52wk Low:46.16
Shares:214.34M
Float Shares:185.00M
Volume Ratio:3.07
T/O Rate:2.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.9212
EPS(LYR):-5.9502
ROE:-79.09%
ROA:-30.12%
PB:15.47
PE(LYR):-31.62

Loading ...

U.S. Stocks on the MOVEX-Abbott, Columbia Financial, Jabil,

Reuters
·
Aug 11

Tango Falls After Wider-than-Expected Quarterly Loss

Reuters
·
Aug 11

U.S. Stocks on the MOVE-Duke Energy, Sea, Cardinal Health

Reuters
·
Aug 11

Truist Raises Revolution Medicines PT on Lung Cancer Pipeline Potential

Reuters
·
Aug 11

BEONE MEDICINES Surges Over 4% in Morning Trading on Strategic Partnership with Revolution Medicines to Accelerate RAS Drug Development

Stock News
·
Aug 11

Analysts’ Top Healthcare Picks: Xencor (XNCR), Revolution Medicines (RVMD)

TIPRANKS
·
Aug 10

BeOne Medicines partners with Revolution Medicines for clinical development

TIPRANKS
·
Aug 10

BeOne Medicines Teams with Revolution Medicines on RAS Cancer Drug Development, Asia Rights Deal

Reuters
·
Aug 10

Beone Medicines - Receives Exclusive Rights to Four Revolution Medicines Assets in Select Asian Markets

THOMSON REUTERS
·
Aug 10

Beone Medicines - to Fund and Conduct Global Phase 3 Study for Ras(on) Inhibitor

THOMSON REUTERS
·
Aug 10

Beone Medicines - Revolution Medicines Eligible for Milestone Payments and Tiered Royalties in Partnered Region

THOMSON REUTERS
·
Aug 10

Revolution Medicines, Inc. : JP Morgan Raises Target Price to $227 from $205

THOMSON REUTERS
·
Aug 10

Analysts Are Bullish on These Healthcare Stocks: Spyre Therapeutics (SYRE), Revolution Medicines (RVMD)

TIPRANKS
·
Aug 08

Revolution Medicines price target raised to $227 from $205 at JPMorgan

TIPRANKS
·
Aug 08

Alphabet Reports Share Stake in SpaceX, Fervo Energy and Parabilis Medicines

Reuters
·
Aug 07

Alphabet Inc. Cuts Share Stake in Revolution Medicines Inc by 10.5% to 2.9 Mln Shares - SEC Filing

THOMSON REUTERS
·
Aug 07

Bernstein Remains a Hold on Revolution Medicines (RVMD)

TIPRANKS
·
Aug 06

Revolution Medicines is Maintained at Buy by Guggenheim

Dow Jones
·
Aug 06

Wedbush Adjusts PT on Revolution Medicines to $201 From $192.10, Maintains Outperform Rating

MT Newswires Live
·
Aug 06

Analysts Have Conflicting Sentiments on These Healthcare Companies: Revolution Medicines (RVMD), Royalty Pharma (RPRX) and Urogen Pharma (URGN)

TIPRANKS
·
Aug 06